Aligos Therapeutics, Inc. (ALGS) NASDAQ
7.97
+0.23(+2.97%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
7.97
+0.23(+2.97%)
Currency In USD
| Market Cap | 92.13M |
| Enterprise Value | 79.07M |
| P/E Ratio | -3.42 |
| PEG Ratio | -0.04 |
| Price/Sales Ratio | 22.56 |
| Price/Book Ratio | 1.55 |
| Enterprise/Revenue | 16.54 |
| Enterprise/EBITDA | -0.42 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -11.07 |
| Operating Margin | -40.25 |
| Return On Assets | -0.27 |
| Return On Equity | -0.28 |
| Revenue | 2.19M |
| Revenue/Share | 0.21 |
| Gross Profit | 1.26M |
| EBITDA | -87.06M |
| Net Income | -24.19M |
| Diluted EPS | -2.45 |
| Total Cash | 77.95M |
| Total Cash/Share | 7.51 |
| Total Debt | 5.25M |
| Total Debt/Equity | 0.1 |
| Current Ratio | 3.9 |
| Book Value Per Share | 5.16 |
| 52-Week Change | 22.99 |
| 52-Week High | 13.69 |
| 52-Week Low | 3.76 |
| Moving Average 50 Days | 7.28 |
| Moving Average 200 Days | 8.68 |
| Average Volume | 55,962 |
| Shares Outstanding | 6.19M |
| % Held by Institutions | 27.11 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | August 19, 2024 |